
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
Serpinb2 (serine (or cysteine) peptidase inhibitor, clade B, member 2) encodes a predicted serine-type endopeptidase inhibitor that may regulate proteolytic activity and contribute to the negative regulation of apoptosis. The protein is associated with the cornified envelope and is expressed in multiple tissues, including the genitourinary system, immune system, mesothelium, respiratory system, and skin. It is orthologous to human SERPINB2.
The H9c2(2-1) cell line is a clonally derived subclone originating from embryonic BD1X rat heart tissue established by B. Kimes and B. Brandt. Although derived from cardiac tissue, H9c2(2-1) cells primarily exhibit skeletal muscle characteristics rather than cardiac properties. Under appropriate culture conditions, the cells can differentiate and form multinucleated myotubes that respond to acetylcholine stimulation, with differentiation enhanced by reducing serum concentration. H9c2(2-1) is widely used as an in vitro model for studying skeletal muscle differentiation, muscle cell biology, neuromuscular signaling, and cellular responses to pharmacological or toxicological treatments.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: E3
Reference Transcript: Senp1-203
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?